Literature DB >> 3918453

Ocular abnormalities in mucolipidosis IV.

K G Riedel, J Zwaan, K R Kenyon, E H Kolodny, L Hanninen, D M Albert.   

Abstract

Systemic findings in a 23-year-old white man with mucolipidosis type IV included early delayed psychomotor development, mental retardation, and mild facial dysplasia. There was urinary excretion of chondroitin sulfate. Ophthalmologic examination showed corneal haze, pigmentary retinopathy, and severe optic atrophy. Light microscopy showed massively engorged superficial and intermediate epithelial cells of both the cornea and the conjunctiva. By transmission electron microscopy these contained fine granular material consistent with acid mucopolysaccharide and concentric lamellar bodies presumably representing phospholipids. This storage phenomenon was also found in macrophages, plasma cells, ciliary epithelial cells, Schwann cells, retinal ganglion cells, and vascular endothelial cells. Light microscopy also disclosed early cataract formation, marked outer retinal degeneration, and optic atrophy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918453     DOI: 10.1016/0002-9394(85)90220-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

1.  Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.

Authors:  Lisa Edelmann; Jianli Dong; Robert J Desnick; Ruth Kornreich
Journal:  Am J Hum Genet       Date:  2002-02-13       Impact factor: 11.025

2.  G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts.

Authors:  S Raghavan; E Leshinsky; E H Kolodny
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 3.  TRPMLs: in sickness and in health.

Authors:  Rosa Puertollano; Kirill Kiselyov
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-21

Review 4.  Role of TRP channels in the regulation of the endosomal pathway.

Authors:  Ken Abe; Rosa Puertollano
Journal:  Physiology (Bethesda)       Date:  2011-02

5.  LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV.

Authors:  Silvia Vergarajauregui; Jose A Martina; Rosa Puertollano
Journal:  J Cell Sci       Date:  2011-01-11       Impact factor: 5.285

Review 6.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

7.  Mucolipidosis type IV: a subtle pediatric neurodegenerative disorder.

Authors:  Joseph S Geer; Steve A Skinner; Ehud Goldin; Kenton R Holden
Journal:  Pediatr Neurol       Date:  2010-03       Impact factor: 3.372

Review 8.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

9.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

10.  Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy.

Authors:  Silvia Vergarajauregui; Rosa Puertollano
Journal:  Autophagy       Date:  2008-07-08       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.